# Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

> **NCT02286986** · PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 26 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Cannabidiol

## Key facts

- **NCT ID:** NCT02286986
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-18
- **Primary completion:** 2019-06-13
- **Final completion:** 2019-06-13
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286986, "Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02286986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*